FDA.reportPublic FDA data

glasdegib 25 MG Oral Tablet

RxCUI
2105858
RxNorm name
glasdegib 25 MG Oral Tablet
Display name
glasdegib 25 MG Oral Tablet
Full name
glasdegib 25 MG Oral Tablet
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:38:50

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
DaurismoGLASDEGIBPfizer Laboratories Div Pfizer Inc204a6f7e-c9a4-472b-abd2-9527bda64d172025-12-12Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2105858

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
204a6f7e-c9a4-472b-abd2-9527bda64d17glasdegib 25 MG Oral Tablet [PSN] · glasdegib 25 MG Oral Tablet [SCD] · glasdegib 25 MG (as glasdegib maleate 32.8 MG) Oral Tablet [SY]311These highlights do not include all the information needed to use DAURISMO safely and effectively. See full prescribing information for DAURISMO. DAURISMO™ (glasdegib) tablets, for oral use Initial U.S. Approval: 201820251212